Marshall Wace’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Buy |
+76,347
| New | +$2.11M | ﹤0.01% | 1431 |
|
|
2025
Q1 | – | Sell |
-86,762
| Closed | -$1.72M | – | 2705 |
|
|
2024
Q4 | $1.72M | Sell |
86,762
-3,809
| -4% | -$75.3K | ﹤0.01% | 1397 |
|
|
2024
Q3 | $2.26M | Buy |
+90,571
| New | +$2.26M | ﹤0.01% | 1224 |
|
|
2023
Q4 | – | Sell |
-158,230
| Closed | -$2.75M | – | 2074 |
|
|
2023
Q3 | $2.75M | Sell |
158,230
-167,312
| -51% | -$2.91M | 0.01% | 952 |
|
|
2023
Q2 | $4.58M | Sell |
325,542
-481,283
| -60% | -$6.78M | 0.01% | 897 |
|
|
2023
Q1 | $8.68M | Buy |
806,825
+658,886
| +445% | +$7.09M | 0.02% | 656 |
|
|
2022
Q4 | $2.22M | Buy |
+147,939
| New | +$2.22M | 0.01% | 1325 |
|
|
2022
Q1 | – | Sell |
-69,723
| Closed | -$821K | – | 2963 |
|
|
2021
Q4 | $821K | Buy |
+69,723
| New | +$821K | ﹤0.01% | 1974 |
|
|
2021
Q1 | – | Sell |
-78,352
| Closed | -$1.38M | – | 2328 |
|
|
2020
Q4 | $1.38M | Sell |
78,352
-69,951
| -47% | -$1.24M | 0.01% | 972 |
|
|
2020
Q3 | $2.27M | Buy |
+148,303
| New | +$2.27M | 0.01% | 737 |
|